Not Rated
|
Fund Size
(0.05% of Investment in Category)
|
Expense Ratio
(0.28% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 23-Oct-25 | 9899.10 | -1.01% | - | 0.08% | 224/353 |
| 1 Month | 30-Sep-25 | 10404.30 | 4.04% | - | 3.27% | 153/351 |
| 3 Month | 30-Jul-25 | 10107.00 | 1.07% | - | 3.16% | 181/336 |
| 6 Month | 30-Apr-25 | 10616.20 | 6.16% | - | 6.99% | 166/314 |
| YTD | 31-Dec-24 | 10288.90 | 2.89% | - | 6.26% | 224/283 |
| 1 Year | 30-Oct-24 | 10435.70 | 4.36% | 4.36% | 5.61% | 192/259 |
| 2 Year | 30-Oct-23 | 15072.90 | 50.73% | 22.74% | 15.31% | 29/185 |
| 3 Year | 28-Oct-22 | 16684.00 | 66.84% | 18.55% | 14.73% | 25/120 |
| 5 Year | 26-Oct-20 | 20907.00 | 109.07% | 15.85% | 19.75% | 35/35 |
| Since Inception | 26-Oct-20 | 20907.00 | 109.07% | 15.85% | 10.09% | 76/346 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 30-Oct-24 | 12000 | 12646.19 | 5.38 % | 10.11 % |
| 2 Year | 30-Oct-23 | 24000 | 27188.22 | 13.28 % | 12.47 % |
| 3 Year | 28-Oct-22 | 36000 | 46679.47 | 29.67 % | 17.59 % |
| 5 Year | 26-Oct-20 | 60000 | 89014.17 | 48.36 % | 15.76 % |
Please check with your Tax Advisor.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 177.2 | 10.89% | 0.05% | 13.34% (Oct 2024) | 10.84% (Aug 2025) | 1.11 L | 73.00 |
| Max Healthcare Institute Ltd. | Hospital | 100.4 | 6.17% | -0.19% | 7.08% (Jun 2025) | 5.85% (Nov 2024) | 90.06 k | 59.00 |
| Cipla Ltd. | Pharmaceuticals | 98.4 | 6.05% | -0.31% | 6.36% (Aug 2025) | 5.7% (Dec 2024) | 65.48 k | 54.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 86.4 | 5.31% | -0.12% | 5.43% (Aug 2025) | 4.75% (Feb 2025) | 11.66 k | 8.00 |
| ELI LILLY ORD SHS | Foreign equity | 85.4 | 5.25% | 0.24% | 6.34% (Feb 2025) | 4.86% (May 2025) | 1.26 k | -12.00 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 82.8 | 5.09% | -0.12% | 5.76% (Dec 2024) | 5.08% (Feb 2025) | 67.65 k | 52.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 78.7 | 4.84% | -0.35% | 6.03% (May 2025) | 4.84% (Sep 2025) | 13.83 k | 9.00 |
| Johnson & Johnson | Foreign equity | 61.9 | 3.80% | 0.18% | 3.8% (Sep 2025) | 2.84% (Dec 2024) | 3.76 k | -40.00 |
| AbbVie Inc | Foreign equity | 56.8 | 3.49% | 0.33% | 3.49% (Sep 2025) | 2.49% (Nov 2024) | 2.76 k | -31.00 |
| Fortis Healthcare Ltd. | Hospital | 55.1 | 3.39% | 0.22% | 3.39% (Sep 2025) | 2.3% (Oct 2024) | 56.83 k | 38.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.11% |
| Net Receivables | Net Receivables | 0.10% |
Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)
Out of 55 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 5 is/are ranked 4 * , 7 is/are ranked 3 * , 1 is/are ranked 2 * , and 41 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Edelweiss Arbitrage Fund - Direct Plan - Growth | 3 | 16053.09 | 0.55 | 1.40 | 3.03 | 7.16 | 7.79 |
| Edelweiss Balanced Advantage Fund - Direct Plan - Growth | NA | 12899.19 | 2.86 | 3.69 | 6.65 | 6.38 | 13.72 |
| Edelweiss Mid Cap Fund - Direct Plan - Growth | 5 | 11731.01 | 4.60 | 4.07 | 11.75 | 7.18 | 26.21 |
| BHARAT Bond FOF - April 2030 - Direct Plan - Growth | NA | 9601.29 | 1.03 | 1.69 | 3.29 | 8.84 | 8.65 |
| Edelweiss Liquid Fund - Direct Plan - Growth | 4 | 8130.21 | 0.49 | 1.46 | 3.08 | 6.82 | 7.13 |
| Edelweiss Nifty PSU Bond Plus SDL Apr 2026 50:50 Index Fund - Direct Plan - Growth | NA | 7069.48 | 0.48 | 1.43 | 3.28 | 7.40 | 7.51 |
| Edelweiss Small Cap Fund - Direct Plan - Growth | 4 | 5057.26 | 3.04 | 0.88 | 12.37 | 0.11 | 22.05 |
| BHARAT Bond FOF - April 2031 - Direct Plan - Growth | NA | 4731.22 | 1.24 | 1.68 | 3.48 | 8.92 | 8.78 |
| BHARAT Bond ETF FOF - April 2032 - Direct Plan - Growth | NA | 4470.99 | 1.16 | 1.76 | 3.12 | 8.73 | 8.74 |
| Edelweiss Large and Mid Cap Fund - Direct Plan - Growth | 3 | 4132.83 | 4.35 | 3.86 | 9.92 | 4.78 | 19.09 |